Osteoarthritis (OA) is the most prevalent form of arthritis, affecting more than 30 million adults in the Unites States. The Arthritis Foundation is transforming the landscape of treatments and advancing OA science by gathering the top clinical research scientists and experts in the field through our OA Clinical Studies (OACS) program. Continue reading Highlights from ACR 2020: The Future of Osteoarthritis Treatment & Research
The American College of Rheumatology (ACR) has selected James Witter, MD, PhD, who serves on the Arthritis Foundation’s Medical and Scientific Advisory Committee, to be designated as an ACR Master, one of ACR’s highest honors. He will receive this recognition along with 17 others during the ACR’s annual meeting in November. Continue reading ACR Honors Arthritis Foundation Advisor
The highlights from day four of the American College of Rheumatology (ACR) annual meeting included topics related to bone health, managing and treating lupus, new treatment guidelines for juvenile idiopathic arthritis (JIA) and evidence-based research for osteoarthritis. Continue reading ACR 2020 Highlights: What to Eat, Bone & Joint Health, Lupus and New JIA Guidelines
Day three of the American College of Rheumatology’s annual meeting Saturday continued with sessions on biologics, osteoarthritis treatments, osteoporosis and more, a highlight was a lecture on COVID-19 by Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH), and a top advisor on COVID-19.
Racial and ethnic disparities in health care and telemedicine was a focus of several presentations at the American College of Rheumatology’s annual meeting Friday, the second of the five-day virtual conference. Continue reading ACR 2020 Highlights: Racial Disparities, COVID-19, Empowering Patients and Pregnancy Among Friday Topics